Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Are large NGS panels really changing patient outcomes?

Are the addition of these new targets really changing patient outcomes globally?

Date

20 Nov 2020

Session

Are large NGS panels really changing patient outcomes?

Topics

Translational Research

Tumour Site

Presenters

Jürgen Wolf

Authors

J. Wolf

Author affiliations

  • Dept. I For Internal Medicine, Center For Integrated Oncology, Uniklinik Köln, 50937 - Cologne/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.